Specific insulin and proinsulin secretion in glucokinase-deficient individuals

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 4, 1999, Pages 427-430

  Pardini, V C ^a,e   Velho, G ^b   Reis, R ^a   Purisch, S ^a   Blanche H ^c   Vieira, J G H ^d   Moises R C S ^d  

^a Hospital Santa Casa de Belo Horizonte   (Brazil)

^b SAINT LOUIS HOSPITAL   (France)

^c FONDATION JEAN DAUSSET CEPH   (France)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e Inst de Patol Clin Hermes Pardini   (Brazil)

Author keywords

Glucokinase; Insulin; MODY; Obesity; Proinsulin

Indexed keywords

GLUCOKINASE; INSULIN; PROINSULIN;

ADULT; ARTICLE; BLOOD; DIABETES MELLITUS; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SECRETION;

ADULT; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOKINASE; HUMANS; INSULIN; MALE; MUTATION; OBESITY; PROINSULIN;

EID: 0033108947     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000400008     Document Type: Article

References (13)

1. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J & Passa P (1993). Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. New England Journal of Medicine, 328: 697-702.
2. Velho G, Froguel P, Clement K, Pueyo ME, Rakotoambinina B, Zouali H, Passa P, Cohen D & Robert JJ (1992). Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet 340: 444-448.
3. Velho G, Petersen KF, Perseghin G, Hwang JH, Rothman DL, Pueyo ME, Cline GW, Froguel P & Shulman GI (1996). Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. Journal of Clinical Investigation, 98: 1755-1761.
4. Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RR & Anderson JH (1992). Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience. Diabetes Care, 15: 666-692.
5. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M & Iwamoto Y (1988). Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 31: 355-360.
6. Haffner SM, Mykkänen L, Valdez RA, Stern MP, Holloway DL, Monterrosa A & Bowsher RR (1994). Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. Journal of Clinical Endocrinology and Metabolism, 79: 1806-1810.
7. Leahy JL (1996). Impaired β-cell function with chronic hyperglycemia: "overworked β-cell" hypothesis. Diabetes Reviews, 4: 298-319.
8. Velho G, Blanché H, Vaxillaire M, Bellanne-Chantelot C, Pardini VC, Timsit J, Passa P, Deschamps I, Robert JJ, Weber IT, Marotta D, Pilkis SJ, Lipkind GM, Bell GI & Froguel P (1997). Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia, 40: 217-224.
9. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997). Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 20: 1183-1197.
10. Stone LM, Kahn SE, Fujimoto WY, Deeb SS & Porte D (1996). A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men. Diabetes, 45: 422-428.
11. Kramer CY (1956). Extension of multiple range tests to group means with unequal number of replications. Biometrics, 12: 309-310.
12. Matschinsky FM (1990). Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes, 39: 647-652.
13. Hattersley AT, Clark PM, Page R, Levy JC, Cox L, Hales CN & Turner RC (1997). Glucokinase deficiency results in a beta-cell disorder characterized by normal fasting plasma proinsulin concentrations. Diabetologia, 40: 1367-1368.